Literature DB >> 6467220

Estradiol and progesterone receptors in malignant gastrointestinal tumors.

V Sica, E Nola, E Contieri, R Bova, M T Masucci, N Medici, A Petrillo, A Weisz, A M Molinari, G A Puca.   

Abstract

Estradiol and progesterone receptors were assayed in tumors from 79 patients with primary colorectal and 56 patients with stomach adenocarcinomas. Eighteen of 79 colorectal cancers contained estradiol receptor, while 34 specimens were positive for progesterone receptor. In stomach cancer, the positive samples were 8 for estradiol and 14 for progesterone receptors. In both types of tumors, the Kd was in the range of 10(-10) M for estradiol and 10(-9) M for progesterone receptor, respectively. In colorectal adenocarcinomas, the presence of progesterone receptor seems to be partially correlated to the presence of estradiol receptor while, in stomach tumors, this correlation is lost. The positivity of at least one receptor in colorectal cancers is higher in the female sex. The contrary occurs for stomach cancer. Sucrose gradient centrifugation showed that cytoplasmic estradiol receptor of stomach cancer sedimented at 8S or 4 to 5S at low ionic strength. The isoelectric point of stomach cancer estradiol receptor is 6.5.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467220

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Type II oestrogen binding sites in human colorectal carcinoma.

Authors:  M Piantelli; R Ricci; L M Larocca; A Rinelli; A Capelli; S Rizzo; G Scambia; F O Ranelletti
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Hydrosalpinx as a Rare Presentation of Synchronous Ovarian and Endometrial Carcinoma - A Case Report.

Authors:  Mahjabeen Khan; Sapna Vinit Amin; Sujatha Bagepalli Srinivas; Roopa Padavagodu Shivananda; Navin Patil
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.

Authors:  Ling-Qiang Zhang; Xin-Sen Xu; Yong Wan; Si-Dong Song; Rui-Tao Wang; Wei Chen; Zhi-Xin Wang; Hu-Lin Chang; Ji-Chao Wei; Ya-Feng Dong; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

4.  Androgen-linked alkylating agents: biological activity in methylnitrosourea-induced rat mammary carcinoma.

Authors:  H P Brix; M R Berger; M R Schneider; W C Tang; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

5.  Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma.

Authors:  Evangelos Chandanos; Carlos A Rubio; Mats Lindblad; Chongqi Jia; Apostolos V Tsolakis; Margaret Warner; Jan-Ake Gustafsson; Jesper Lagergren
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

6.  Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results.

Authors:  A Di Leo; C Messa; F Russo; G Misciagna; V Guerra; R Taveri; S Leo
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

7.  Steroid hormone receptors in three human gastric cancer cell lines.

Authors:  C W Wu; Y F Chang; T H Yeh; T J Chang; W Y Lui; F K P'Eng; C W Chi
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

Review 8.  Reproductive factors and colorectal cancer.

Authors:  C La Vecchia; S Franceschi
Journal:  Cancer Causes Control       Date:  1991-05       Impact factor: 2.506

Review 9.  Estrogen receptors in gastric cancer: Advances and perspectives.

Authors:  Muhammad Saif Ur Rahman; Jiang Cao
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

10.  Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States).

Authors:  K P Cantor; C F Lynch; D Johnson
Journal:  Cancer Causes Control       Date:  1993-11       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.